Scientific updates

Recent developments in research

• 
  Connecting the Dots: SCLCDecember 22, 2025
• 
  Connecting the Dots: ROS1December 15, 2025
• 
  Announcing the 2025 LCRF | Boehringer Ingelheim Early Career Investigator AwardsDecember 9, 2025
• 
  LCRF announces 2025 Scientific Research Grant AwardsDecember 2, 2025
• 
  Science Update | Fall 2025November 14, 2025
• 
  Scientific Symposium covers hot topics in lung cancerNovember 6, 2025

---

Science Made Simple

• 
  Sevabertinib for HER2+ lung cancerDecember 1, 2025
• 
  Zongertinib for HER2+ lung cancerAugust 28, 2025
• 
  Sunvozertinib for EGFR Exon 20+ NSCLCAugust 25, 2025
• 
  NeoADAURA trial shows promising resultsJuly 28, 2025
• 
  ADC for EGFR+ lung cancer gets accelerated approvalJuly 7, 2025
• 
  New treatment for ROS1+ non-small cell lung cancerJune 25, 2025
• 
  Accelerated approval for c-MET directed ADCJune 12, 2025
• 
  1-year updates from research granteesMay 27, 2025
• 
  Inhibiting Tim-1 to enhance immunotherapyApril 29, 2025

---

Recent FDA approvals